4-(1-Cyclohexen-1-yl)morpholine

We are 4-(1-Cyclohexen-1-yl)morpholine CAS:670-80-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(1-Cyclohexen-1-yl)morpholine
CAS.NO:670-80-4
Molecular Formula: C10H17NO
Molecular Weight: 167.24800

Synonyms:
4-(cyclohexen-1-yl)morpholine

Physical and Chemical Properties:
Density: 0.995 g / mL at 25 ° C (lit.)
Boiling point: 118-120 ° C10 mm Hg (lit.)
Flash point: 155 ° F
Refractive index: n20 / D 1.514 (lit.)

Specification:
Appearance:Colorless liquid
Purity:≥98.0%
Moisture Content: 0.25%
Impurity: 0.3%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.

Related News: At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.1- (2-fluoro-bencil) -1H-pirazolo [3,4-b] piridina-3-carboxamidina clorhidrato CAS:256499-19-1 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.3,5-bis(chloromethyl)-2,2,6,6-tetramethylheptan-4-one CAS:106993-42-4 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.(R)-(+)-Propylene carbonate CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.